XML 40 R20.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of the Error Correction

A summary of corrections reflecting the prior period impact to the Company’s Consolidated Statement of Operations, for the year ended December 31, 2022, are shown below:

 

   December 31, 2022   Correction   As Corrected
December 31, 2022
 
General and administrative expense  $198,978   $339,818   $538,796 
Research and development expense   1,488,530    (339,818)   1,148,712 
Net Loss  $1,687,508   $-   $1,687,508 
Schedule of Cash and Cash Equivalents

Cash and cash equivalents include cash in bank accounts and money market funds with maturities of less than three months from inception, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. As of December 31, 2023 and 2022, cash and cash equivalents consisted of the following:

 

   December 31,   December 31, 
   2023   2022 
Cash  $1,550,098   $5,411,378 
Money market funds   1,026,318    3,005,825 
Total cash and cash equivalents  $2,576,416   $8,417,203 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Set out below are the Company’s financial instruments that are required to be remeasured at fair value on a recurring basis and their fair value hierarchy as of December 31, 2023 (none for December 31, 2022):

 

December 31, 2023  Level 1   Level 2   Level 3   Carrying Value 
Assets                    
Marketable Securities:                    
United States Treasury Bonds  $2,887,215   $-   $-   $2,887,215 
Total Assets  $2,887,215   $-   $-   $2,887,215 
Liabilities                    
Derivative Liability - Warrants  $-   $-   $410,660   $410,660 
Derivative Liability - Accelerated feature   -    -    3,852    3,852 
Total Liabilities  $-   $-   $414,512   $414,512 
Schedule of Useful Lives for Property Plant Equipment

 

Furniture   5 years 
Computers and equipment   5 years 
Research Equipment   10 years 
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

For the years ended December 31, 2023 and 2022, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

 

   December 31,   December 31, 
   2023   2022 
Convertible notes (Note 5)   959,513    - 
Warrant (Note 6)   1,446,155    356,810 
Restricted stock units (Note 6)   197,855    - 
    2,603,523    356,810